Tag: VTE

Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

Prolonged TV watching may increase risk of venous thromboembolism

A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...

FDA approval granted to calf stimulation device for patients at high...

UK-based Sky Medical Technology has received US Food and Drug Administration (FDA) 510(k) clearance for its "geko" device for stimulation of the calf muscles...